Triamcinolone aminobenzal benzamidoisobutyrate

Triamcinolone aminobenzal benzamidoisobutyrate (TBI-PAB; brand name Taucorten) is a synthetic glucocorticoid corticosteroid which is no longer marketed.[1][2]

Triamcinolone aminobenzal benzamidoisobutyrate
Clinical data
Trade namesTaucorten
Other namesTBI-PAB; TBI/PAB; Tbi-Pab; 16α,17α-(4-Dimethylamino-
benzyliden)triamcinolone 21-(β-benzoylamino)isobutyrate; 21-(3-(benzoylamino)-2-methyl-1-oxopropoxy)-16α,17α-(((4-(dimethylamino)phenyl)-
methylene)bis(oxy))-9α-fluoro-11β-hydroxypregna-1,4-diene-3,20-dione
Drug classCorticosteroid; Glucocorticoid
Identifiers
CAS Number
PubChem CID
ChemSpider
Chemical and physical data
FormulaC41H47FN2O8
Molar mass714.831 g·mol−1
3D model (JSmol)

References

  1. J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 1228–. ISBN 978-1-4757-2085-3.
  2. William Martindale; Royal Pharmaceutical Society of Great Britain. Dept. of Pharmaceutical Sciences (1993). The Extra Pharmacopoeia. Pharmaceutical Press. p. 740. ISBN 978-0-85369-300-0.



This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.